1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow BRII-179: new trials by email Literature Review of BRII-179 trials Research Report on BRII-179
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE) BRII-179, BRII-835 (VIR-2218), PEG-IFNα - Chronic Hepatitis B Virus (HBV) Infection | Phase 2 | Recruiting | Brii Biosciences Limited | 250 | 2024-10-31 | 2026-10-22 |
| Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH) BRII-179, BRII-835 (VIR-2218), PEG-IFNα - For Treatment of Chronic Hepatitis B Virus Infection | Phase 2 | Completed | Brii Biosciences Limited | 150 | 2024-08-06 | 2026-10-21 |
Hepatitis B (1) · Hepatitis B, Chronic (1) · Infections (1)
China (2)